Search Count: 27
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: 799 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: X3W |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.68 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: X3R |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2022-11-30 Classification: CELL CYCLE Ligands: X3N |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.24 Å Release Date: 2021-06-02 Classification: TRANSCRIPTION Ligands: G9J, ZNM |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.46 Å Release Date: 2020-09-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, VPD |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.70 Å Release Date: 2020-09-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: ZN, CA, NAG, VPG, PO4 |
 |
Crystal Structure Of Estrogen Receptor Alpha In Complex With Receptor Degrader 6
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2020-07-01 Classification: NUCLEAR PROTEIN Ligands: G9J, U6D |
 |
Organism: Homo sapiens, Bos taurus
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2016-01-27 Classification: Transferase/Transferase Inhibitor Ligands: 5H2 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2016-01-27 Classification: Transferase/Inhibitor Ligands: 5H5, EDO |
 |
Organism: Homo sapiens, Bos taurus
Method: X-RAY DIFFRACTION Resolution:2.64 Å Release Date: 2016-01-27 Classification: Transferase/Inhibitor Ligands: 5H5 |
 |
Back Pocket Flexibility Provides Group-Ii Pak Selectivity For Type 1 Kinase Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2014-02-12 Classification: transferase/transferase inhibitor Ligands: 7KC |
 |
Back Pocket Flexibility Provides Group-Ii Pak Selectivity For Type 1 Kinase Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2014-02-12 Classification: transferase/transferase inhibitor Ligands: 2OL |
 |
Back Pocket Flexibility Provides Group-Ii Pak Selectivity For Type 1 Kinase Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2014-02-12 Classification: transferase/transferase inhibitor Ligands: 2OL |
 |
Back Pocket Flexibility Provides Group-Ii Pak Selectivity For Type 1 Kinase Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2014-02-12 Classification: transferase/transferase inhibitor Ligands: 2OQ |
 |
Back Pocket Flexibility Provides Group-Ii Pak Selectivity For Type 1 Kinase Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2014-02-12 Classification: transferase/transferase inhibitor Ligands: 2OO |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2013-08-07 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: ANP, MG, EUI |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2012-05-23 Classification: TRANSFERASE Ligands: ANP, MN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2012-05-23 Classification: TRANSFERASE Ligands: 0RF |
 |
Discovery Of Gdc-0980: A Potent, Selective, And Orally Available Class I Phosphatidylinositol 3-Kinase (Pi3K)/Mammalian Target Of Rapamycin (Mtor) Kinase Inhibitor For The Treatment Of Cancer
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.79 Å Release Date: 2011-11-02 Classification: TRANSFERASE/TRANSFERASE INHIBITOR Ligands: 980 |